![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Pharmacogenetics Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina
The nuclear constitutive active receptor (CAR) is a key transcription factor regulating phenobarbital (PB)-inducible transcription of various hepatic genes that encode xenobiotic/steroid-metabolizing enzymes. CAR is retained in the cytoplasm of noninduced livers and translocates into the nucleus after PB induction (Mol Cell Biol19:6318-6322, 1999). HepG2 cells lack the capability of retaining CAR in the cytoplasm; thus, the receptor spontaneously accumulates in the nucleus. We have now cloned and characterized a tetratricopeptide repeat (TPR) protein, designated cytoplasmic CAR retention protein (CCRP), for its ability to accumulate the receptor in the cytoplasm of cotransfected HepG2 cells. CCRP directly interacts with the ligand-binding domain of CAR and mediates the formation of a cytoplasmic CAR-CCRP-90-kDa heat shock protein (hsp90) ternary complex. Simultaneous expression of fluorescent protein-tagged CAR and CCRP reveals their colocalization with tubulin in mouse liver in vivo. Thus, these results indicate that CCRP may be a component of the CAR-hsp90 complex and involved in retaining the receptor in the cytoplasm of both HepG2 cells and probably in vivo liver cells.
Received May 6, 2003; accepted August 4, 2003.
Address correspondence to: Dr. Masahiko Negishi, Pharmacogenetics section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709. E-mail address, negishi{at}niehs.nih.gov
This article has been cited by other articles:
|
|
 |
|
  J. M. Phillips, L. D. Burgoon, and J. I. Goodman The Constitutive Active/Androstane Receptor Facilitates Unique Phenobarbital-Induced Expression Changes of Genes Involved in Key Pathways in Precancerous Liver and Liver Tumors Toxicol. Sci., August 1, 2009; 110(2): 319 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Li, T. Chen, J. Cottrell, and H. Wang Nuclear Translocation of Adenoviral-Enhanced Yellow Fluorescent Protein-Tagged-Human Constitutive Androstane Receptor (hCAR): A Novel Tool for Screening hCAR Activators in Human Primary Hepatocytes Drug Metab. Dispos., May 1, 2009; 37(5): 1098 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Audet-Walsh and A. Anderson Dexamethasone Induction of Murine CYP2B Genes Requires the Glucocorticoid Receptor Drug Metab. Dispos., March 1, 2009; 37(3): 580 - 588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Smith and D. O. Toft Minireview: The Intersection of Steroid Receptors with Molecular Chaperones: Observations and Questions Mol. Endocrinol., October 1, 2008; 22(10): 2229 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Merrell, J. P. Jackson, L. M. Augustine, C. D. Fisher, A. L. Slitt, J. M. Maher, W. Huang, D. D. Moore, Y. Zhang, C. D. Klaassen, et al. The Nrf2 Activator Oltipraz Also Activates the Constitutive Androstane Receptor Drug Metab. Dispos., August 1, 2008; 36(8): 1716 - 1721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harmsen, A. S. Koster, J. H. Beijnen, J. H. M. Schellens, and I. Meijerman Comparison of Two Immortalized Human Cell Lines to Study Nuclear Receptor-Mediated CYP3A4 Induction Drug Metab. Dispos., June 1, 2008; 36(6): 1166 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Inoue and M. Negishi Nuclear Receptor CAR Requires Early Growth Response 1 to Activate the Human Cytochrome P450 2B6 Gene J. Biol. Chem., April 18, 2008; 283(16): 10425 - 10432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sueyoshi, R. Moore, J. Sugatani, Y. Matsumura, and M. Negishi PPP1R16A, The Membrane Subunit of Protein Phosphatase 1{beta}, Signals Nuclear Translocation of the Nuclear Receptor Constitutive Active/Androstane Receptor Mol. Pharmacol., April 1, 2008; 73(4): 1113 - 1121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Guo, J. Sarkar, K. Suino-Powell, Y. Xu, K. Matsumoto, Y. Jia, S. Yu, S. Khare, K. Haldar, M. S. Rao, et al. Induction of Nuclear Translocation of Constitutive Androstane Receptor by Peroxisome Proliferator-activated Receptor {alpha} Synthetic Ligands in Mouse Liver J. Biol. Chem., December 14, 2007; 282(50): 36766 - 36776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xia and B. Kemper Subcellular Trafficking Signals of Constitutive Androstane Receptor: Evidence for a Nuclear Export Signal in the DNA-Binding Domain Drug Metab. Dispos., September 1, 2007; 35(9): 1489 - 1494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Koike, R. Moore, and M. Negishi Extracellular Signal-Regulated Kinase Is an Endogenous Signal Retaining the Nuclear Constitutive Active/Androstane Receptor (CAR) in the Cytoplasm of Mouse Primary Hepatocytes Mol. Pharmacol., May 1, 2007; 71(5): 1217 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Stoner, S. S. Auerbach, S. M. Zamule, S. C. Strom, and C. J. Omiecinski Transactivation of a DR-1 PPRE by a human constitutive androstane receptor variant expressed from internal protein translation start sites Nucleic Acids Res., April 1, 2007; 35(7): 2177 - 2190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nakamura, R. Moore, M. Negishi, and T. Sueyoshi Nuclear Pregnane X Receptor Cross-talk with FoxA2 to Mediate Drug-induced Regulation of Lipid Metabolism in Fasting Mouse Liver J. Biol. Chem., March 30, 2007; 282(13): 9768 - 9776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Auerbach, J. G. DeKeyser, M. A. Stoner, and C. J. Omiecinski CAR2 Displays Unique Ligand Binding and RXR{alpha} Heterodimerization Characteristics Drug Metab. Dispos., March 1, 2007; 35(3): 428 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kawase, Y. Tsunokuni, and M. Iwaki Effects of Alterations in CAR on Bilirubin Detoxification in Mouse Collagen-Induced Arthritis Drug Metab. Dispos., February 1, 2007; 35(2): 256 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rencurel, M. Foretz, M. R. Kaufmann, D. Stroka, R. Looser, I. Leclerc, G. da Silva Xavier, G. A. Rutter, B. Viollet, and U. A. Meyer Stimulation of AMP-Activated Protein Kinase Is Essential for the Induction of Drug Metabolizing Enzymes by Phenobarbital in Human and Mouse Liver Mol. Pharmacol., December 1, 2006; 70(6): 1925 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sakai, H. Iwata, E.-Y. Kim, O. Tsydenova, N. Miyazaki, E. A. Petrov, V. B. Batoev, and S. Tanabe Constitutive Androstane Receptor (CAR) as a Potential Sensing Biomarker of Persistent Organic Pollutants (POPs) in Aquatic Mammal: Molecular Characterization, Expression Level, and Ligand Profiling in Baikal Seal (Pusa sibirica) Toxicol. Sci., November 1, 2006; 94(1): 57 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Hosseinpour, R. Moore, M. Negishi, and T. Sueyoshi Serine 202 Regulates the Nuclear Translocation of Constitutive Active/Androstane Receptor Mol. Pharmacol., April 1, 2006; 69(4): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Jia, G. L. Guo, S. Surapureddi, J. Sarkar, C. Qi, D. Guo, J. Xia, P. Kashireddi, S. Yu, Y.-W. Cho, et al. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity PNAS, August 30, 2005; 102(35): 12531 - 12536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Xia and B. Kemper Structural Determinants of Constitutive Androstane Receptor Required for Its Glucocorticoid Receptor Interacting Protein-1-mediated Nuclear Accumulation J. Biol. Chem., February 25, 2005; 280(8): 7285 - 7293. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Swales, S. Kakizaki, Y. Yamamoto, K. Inoue, K. Kobayashi, and M. Negishi Novel CAR-mediated Mechanism for Synergistic Activation of Two Distinct Elements within the Human Cytochrome P450 2B6 Gene in HepG2 Cells J. Biol. Chem., February 4, 2005; 280(5): 3458 - 3466. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kodama, C. Koike, M. Negishi, and Y. Yamamoto Nuclear Receptors CAR and PXR Cross Talk with FOXO1 To Regulate Genes That Encode Drug-Metabolizing and Gluconeogenic Enzymes Mol. Cell. Biol., September 15, 2004; 24(18): 7931 - 7940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wang, S. Faucette, R. Moore, T. Sueyoshi, M. Negishi, and E. LeCluyse Human Constitutive Androstane Receptor Mediates Induction of CYP2B6 Gene Expression by Phenytoin J. Biol. Chem., July 9, 2004; 279(28): 29295 - 29301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Swales and M. Negishi CAR, Driving into the Future Mol. Endocrinol., July 1, 2004; 18(7): 1589 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Jackson, S. S. Ferguson, R. Moore, M. Negishi, and J. A. Goldstein The Constitutive Active/Androstane Receptor Regulates Phenytoin Induction of Cyp2c29 Mol. Pharmacol., June 1, 2004; 65(6): 1397 - 1404. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
